TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/11/2023
Voltar para busca
Dado oficial do USPTO
AM ANTAROS MEDICAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
17/11/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42, 44
Data de depósito
11/08/2020
Data de registro
02/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/11/2021
Última transação
17/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Mölndal, SE
Examinador
NEPTUNE, EVONNE
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized letters "AM" with the letter "A" made up of a light blue arch, a red arch, and a dark blue rectangle, and with the letter "M" made up of a purple arch, a pink rectangle and a green rectangle, all appearing in larger font to the left of the stacked stylized words "ANTAROS MEDICAL" in black. The white represents background and is not a feature of the mark.
Titulares e representantes
Titulares
Antaros Medical AB
Representantes
Sara M. Bauer Womble Bond Dickinson (US) LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Consultancy relating to drug development; drug discovery services; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to scientific research focusing on imaging and development of pharmaceuticals; scientific research for development of pharmaceuticals and for medical purposes; pharmaceuticals research relating to imaging; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research services; industrial analysis and research services in the field of pharmaceuticals; biochemistry research services; provision of information and data relating to medical and veterinary pharmaceutical research and development; preparing and providing medical and scientific research information and reports in relation to pharmaceuticals and clinical tests; research and development relating to imaging for the pharmaceuticals industry; conducting clinical trialsfor others; conducting clinical trials for pharmaceutical products for others; clinical research relating to imaging; medical research relating to imaging; scientific research relating to imaging; development of test methodsspecificationsprocedurestechniques relating to imaging; research and development relating to imaging; scientific research and development relating to imaging; scientific research and analysis in the field of development of pharmaceuticals; development in relation to methodsspecificationsprocedurestechniques for testing relating to imaging; services relating to pharmaceutical research and development relating to imaging; research and development in the pharmaceuticals and biotechnology fields relating to imaging; scientific and technological services relating to imagingresearch; scientific services and design relating thereto relating to imagingnamely clinical research in the field of pharmaceuticals; scientific services and research relating thereto relating to imagingnamely clinical research in the field of pharmaceuticals; analytical laboratory servicesmedical imaging analysis; testingauthentication and quality control in the field of pharmaceuticalsfor others; quality assurance consultancy in the field of pharmaceuticals; clinical study design services; pharmaceutical drug development servicesanalysis of X-ray images for drug development; compilation of data in the nature of medical reports for research purposes
Classe 44
x-ray technician services; medical evaluation services for pharmaceutical research and development; medical imaging services; advisory services relating to medical services; advisory services relating to pharmaceuticals; issuing of medical reports in the field of pharmaceutical research and development; compilation of data in the nature of medical reports for diagnostic purposes; conducting of medical examinations for pharmaceutical research and development; x-ray examinations for medical purposes; medical diagnostic services; preparation of reports relating to medical matters for pharmaceutical research and development; advisory services relating to medical instruments; all the aforesaid services in this class being used for providing medical information on the development of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/08/2021
PUBO
PUBLISHED FOR OPPOSITION
17/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2020
GNRT
NON-FINAL ACTION E-MAILED
06/12/2020
CNRT
NON-FINAL ACTION WRITTEN
06/12/2020
DOCK
ASSIGNED TO EXAMINER
05/12/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
15/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/09/2020
NWAP
NEW APPLICATION ENTERED
14/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AM ANTAROS MEDICAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.